StoneX Group’s Enzo Biochem, Inc. ENZ Stock Holding History

StoneX Group’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-14,050	Closed	-$48K	–	496
2021 Q1	$48K	Buy	+14,050	New	+$43.7K	0.01%	409

Other funds holding ENZ

HFA

Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RAM

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EGA

Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCA

VIEX Capital Advisors Sunny Isles Beach, Florida $30.9M AUM 55.48% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

StoneX Group's ENZ Position: Q2 2021 in Review

StoneX Group sold out of Enzo Biochem, Inc. (ENZ) in Q2 2021, closing a stake of 14,050 shares — an estimated $48K sold.

StoneX Group first reported a position in ENZ in Q1 2021 and held it in 1 quarter. The position peaked at $48K in Q1 2021. 72 funds tracked by Wall St. Rank hold ENZ as of Q2 2021.

StoneX Group reported no remaining Enzo Biochem, Inc. position as of Q2 2021 after selling out during the quarter.
StoneX Group sold 14,050 Enzo Biochem, Inc. shares in Q2 2021, an estimated $48K.
StoneX Group first reported a position in Enzo Biochem, Inc. in Q1 2021 and held it in 1 quarter.
StoneX Group's Enzo Biochem, Inc. position peaked at $48K in Q1 2021.
72 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2021.

Based on StoneX Group's 13F filing for Q2 2021, filed 6 Aug 2021.